AstraZeneca gets first supply deals for COVID vaccine, eyes late stage trials

Reuters India

21 May 2020 0 shares 1 views

AstraZeneca gets first supply deals for COVID vaccine, eyes late stage trials

Reuters India

Published 21 May 2020

AstraZeneca Plc said on Thursday it had received the first agreements to supply at least 400 million doses of the COVID-19 vaccine it is developing with the University of Oxford.

Full Article

Related news coverage

The untold story of Moderna as the biotech's coronavirus vaccine faces a test that could make it one of the most consequential startups of all time (MRNA)

Business Insider 23 May 2020

· The biotech Moderna has skyrocketed to global prominence, leading the world's race for a coronavirus vaccine.
· The..

NA Proactive news snapshot: Genprex, PyroGenesis Canada, Internet of Things, Ozop Surgical, Zynerba Pharmaceuticals UPDATE …
Proactive Investors 26 May 2020
The ‘Novel’ Aspect Of Novel Coronavirus: Hard To Predict Prognosis – Analysis
Eurasia Review 18 May 2020

AstraZeneca gets first supply deals for COVID vaccine, eyes late stage trials

AstraZeneca gets first supply deals for COVID vaccine, eyes late stage trials

You might like

Related news coverage

The untold story of Moderna as the biotech's coronavirus vaccine faces a test that could make it one of the most consequential startups of all time (MRNA)

Advertisement